
ABOUT MEDABLE
Medable’s mission is to get effective therapies to patients faster while expanding clinical research to every body, eliminating critical barriers to access such as income status, geography, & race. Medable offers a proven decentralized clinical trial platform that shortens trial timelines, creates operational efficiencies, and expands trial access to anyone worldwide using a combination of screening, eConsent, eCOA, ePRO, real-world data, connected sensors & more.
Founded by visionary CEO Dr. Michelle Longmire after discovering firsthand the difficulties of finding research patients, Medable’s platform is designed by a combination of clinicians, patients, and tech experts to ease the experience for all trial stakeholders. The result is over 150+ decentralized trials conducted across 60+ countries with over 1 million patients accessing our platform today.
A pioneer in patient-centric trials, Medable has been ranked the number one provider of decentralized clinical trials by the Everest Group, and recently collaborated with Tufts CSDD to release the first financial modeling showcasing the benefits of DCTs. Medable DCTs have now demonstrated net financial benefits of up to 5x & 14x greater than the initial upfront investment required for phase ll & phase lll studies, respectively. Additionally, our digital certification program has helped teach decentralized and patient-centric clinical trial methods to over 1,000+ of our industry peers.
Find out how Medable can partner with your organization to digitally transform your clinical protocols. Your research teams can experience benefits such as; improved patient experience, higher quality outcomes data, & savings of US$25,000,000+ for individual studies. Please visit www.Medable.com for further information.
FEATURED CONTENT
-
Tufts CSDD outlines their argument as to why and how a decentralized clinical model can drive greater savings over time than traditional trials.
-
Feeling left behind by the sudden digitization of clinical trials? Learn how to take the right first step with this short blog.
-
Explore five key reasons patients may opt not to participate in clinical trials and learn how technology can help overcome patients’ concerns.
-
Explore how technological advancements, innovative business models, increased wearables support, FDA’s push to the industry to adopt DCTs, and a holistic approach to clinical trials have proliferated the DCT landscape.
-
As telehealth solutions and mobile health devices help empower decentralized clinical trials, discover how study sponsors look for ways to further improve the patient and site experience while delivering high-quality data.
-
Oncology trials placed a heavy burden on patients due to travel burden, poor patient experience and multi-year clinical trial commitments. Sites also struggle with cancer trials due to enrollment delays, complex data workflows, and multiple amendments requiring re-consents. Today, there is a more effective, patient-first solution.
-
In this white paper, learn how the informed consent process helps ensure trial participants are adequately educated about the trial and what will be required of them during the process, while confirming their willingness to enroll.
-
In this Q&A, learn from Rosamund Round, Vice President, Patient Innovation Center and Decentralized Trials at Parexel, on how to include patients in the design of clinical trials for the benefit of all stakeholders.
-
As the Senior Director and Co-Owner of Coastal Carolina Research Center, Nathan Morton provides strategic planning and operational oversight for a dedicated research center and clinical staff of 50.
-
A lack of access, awareness, and trust has caused an extreme lack of inclusivity in medical science. Discover a path forward for the industry that addresses diversity challenges using a combination of local pharmacy access and decentralized trial technologies.
-
Discover the pros and cons of telehealth visits and what can be done to continuously improve them.
-
Gain insight into why the call center must be viewed as an integral component of the clinical trial experience.
-
Discover the important role of clinician reported outcomes (ClinROs) when it comes to regulatory submissions.
-
Learn how drug makers worldwide need to ensure that conditions for bias are not created as a result of access to devices or WiFi when it comes to clinical research.
-
The US has already achieved its target of 100 million Americans vaccinated in 100 days. Despite this huge milestone, discover how the registration for the vaccine itself has been anything but simple.
-
Learn why you don't need to take an all-or-nothing approach when it comes to decentralized trials.
-
At the beginning of the pandemic, thousands of clinical trials were suspended for the safety of investigators and participants alike. Once the FDA issued guidance for conducting trials virtually, discover the ways the industry embraced them and their benefits.
-
Find out how digital biomarkers stand to have a profound impact on, and even enable, the digital transformation of the healthcare industry and DCTs.
-
Learn how decentralized clinical trials featuring technology-enabled communications are empowering researchers to create a more patient-centric clinical trial and transforming the clinical trial experience for patients.
-
Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
CONTACT INFORMATION
Medable
525 University Ave, Suite A70
Palo Alto, CA 94301
UNITED STATES
WEBINARS
-
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
-
Learn how and why unified platforms are effective at delivering better patient access and shortening clinical trial timelines with this webinar.
-
Discover best practices, and see real examples, of how to successfully drive the transformation of clinical development to get higher patient engagement and retention using digital technologies.
-
Hear from young cancer survivor Dr. Lindsay Matt, and Medable SMEs as they document what challenges patients face in clinical trials, and how to help alleviate them with modern technology.
-
Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.
-
In this on-demand webinar attendees will learn about the common misconceptions surrounding eConsent, as well as the benefits they can realize through a digitally-enabled approach.
-
This webinar provides insight into an understanding of hybrid and decentralized clinical trials (DCT), the facts and fiction around decentralized trials, and why decentralized trials are not an all or nothing approach.
-
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
-
In this webinar, Medable SMEs take you through the end-to-end process of conducting decentralized clinical research, including benefits, common pitfalls and challenges, and more.
-
In this webinar, industry experts share their perspectives on how to address drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act.
-
In this webinar, learn how to develop a unified platform experience, deploy flexible solutions to enable diverse patient-invested clinical trials, and contextualize data to make actionable data points for practitioners' workflows.
-
In this free webinar, learn how to update your clinical data strategy that ensures you can scale trials globally while decreasing the overall burden on sites and patients.
-
In this webinar, experts discuss how enriching oncology clinical trials with RWD generates deeper insights and improves operational efficiency to achieve better patient outcomes.
-
What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.
-
Find out why bringing the on-site experience into patients' homes can make clinical research, and therefore treatments, work for everybody.
FEATURED SOLUTIONS
-
Medable’s oncology offering simplifies data collection for sites and sponsors while keeping patients safe, comfortable, and engaged from any location.
-
Learn how Medable’s oncology offering simplifies data collection for sites and sponsors while keeping patients safe, comfortable, and engaged from any location.
-
At Medable, we’re always looking to understand the changing environment of clinical research, and how we can help clients overcome the various challenges, risks, and scenarios that these changes bring.
-
Learn about our mission of making clinical trials easy to participate in around the world, as well as what Medable can do for you, with this overview.
-
Accelerate research and drive operational efficiencies with multi-modal, scalable digital solutions for oncology, vaccine, and cardiovascular / metabolic studies.
-
Discover how Medable has developed an industry first certification program designed to provide your workforce with the specialized tools, knowledge, and skills necessary to rapidly scale decentralized and hybrid trials.
-
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
Medable eCOA is designed to enhance your decentralized trial capabilities with all features native to the platform. Modular by design, use what you need, not what you don’t.
-
Learn how to optimize patient access to clinical research with a modern eConsent platform that delivers an engaging, flexible and scalable user experience.
-
Voted #1 DCT platform by the Everest Group, the Medable Partner Network connects and empowers partners and sponsors to accelerate therapeutic development, helping to create more effective medicines and get them to more patients, faster.
-
Limited access to clinical trials has had a direct impact on the development of new medicines. Explore Medable's vision to open scientific research to the world using a platform designed for everybody, every biology, everywhere.
-
At Medable, we believe health and access to clinical trials is a human right, and participation should be easy. We understand that inclusive medicine removes barriers to clinical trials creating new trial efficiencies that amplify science, enabling you to bring treatments to market faster than ever before.